MedTrace Logo

Use of Dexamethasone in Uterine Artery Embolization

NCT02056717 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2015-04-17

No results posted yet for this study

Summary

The primary purpose of this study is to investigate the effects of dexamethasone on inflammatory reactions after uterine artery embolization. The secondary purpose of this study it to investigate the effects of dexamethasone on postembolization syndrome (severe pain, nasea and vomiting).

Conditions

  • Uterine Myoma
  • Adenomyosis

Interventions

DRUG

Dexamethasone

Administration of dexamethasone 10 mg IV 1 h before UAE

DRUG

Normal saline

Administration of normal saline 2 mL IV 1 h before UAE

Sponsors & Collaborators

  • Severance Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02056717 on ClinicalTrials.gov